Viome is a leader in microbiome health science and personalized health solutions, focusing on revolutionizing early disease detection and preventative healthcare. The company aims to make illness optional by making early detection accessible to all, leveraging its innovative diagnostic technologies and expanding its offerings in the health sector.
Viome LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Viome had 101 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Viome had 21,438 followers as of October 12, 2026. The number of followers increased by 63 (0.29%) week-over-week.
A snapshot of major enterprise customers that use this private company’s products or services, highlighting its commercial reach and market adoption.
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 14, 2025 | Series D | $25.00M | ― |
| Investor Name | Funding Round |
|---|---|
| Khosla Ventures | Series D |
| Bold Capital | Series D |
| WRG Ventures | Series D |
| Marc Benioff | Series D |
A snapshot of private companies similar to Viome, helping you discover and navigate related company profiles.

